InfuSystems Holdings Inc (INFU)
6.44
+0.10
(+1.58%)
USD |
NYAM |
May 17, 16:00
6.47
+0.03
(+0.47%)
After-Hours: 20:00
InfuSystems Holdings Enterprise Value: 166.25M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 166.25M |
| May 16, 2024 | 164.12M |
| May 15, 2024 | 171.57M |
| May 14, 2024 | 175.83M |
| May 13, 2024 | 177.32M |
| May 10, 2024 | 184.14M |
| May 09, 2024 | 190.10M |
| May 08, 2024 | 198.19M |
| May 07, 2024 | 201.81M |
| May 06, 2024 | 194.57M |
| May 03, 2024 | 189.25M |
| May 02, 2024 | 186.89M |
| May 01, 2024 | 194.55M |
| April 30, 2024 | 188.81M |
| April 29, 2024 | 191.15M |
| April 26, 2024 | 201.78M |
| April 25, 2024 | 190.93M |
| April 24, 2024 | 196.46M |
| April 23, 2024 | 199.44M |
| April 22, 2024 | 193.70M |
| April 19, 2024 | 203.48M |
| April 18, 2024 | 194.76M |
| April 17, 2024 | 196.46M |
| April 16, 2024 | 197.53M |
| April 15, 2024 | 197.10M |
| Date | Value |
|---|---|
| April 12, 2024 | 200.08M |
| April 11, 2024 | 198.38M |
| April 10, 2024 | 200.72M |
| April 09, 2024 | 201.35M |
| April 08, 2024 | 202.20M |
| April 05, 2024 | 205.82M |
| April 04, 2024 | 208.58M |
| April 03, 2024 | 203.69M |
| April 02, 2024 | 205.61M |
| April 01, 2024 | 216.68M |
| March 31, 2024 | 211.57M |
| March 28, 2024 | 211.11M |
| March 27, 2024 | 216.00M |
| March 26, 2024 | 209.83M |
| March 25, 2024 | 214.94M |
| March 22, 2024 | 219.83M |
| March 21, 2024 | 220.04M |
| March 20, 2024 | 217.70M |
| March 19, 2024 | 216.25M |
| March 18, 2024 | 217.95M |
| March 15, 2024 | 225.58M |
| March 14, 2024 | 220.07M |
| March 13, 2024 | 230.66M |
| March 12, 2024 | 222.61M |
| March 11, 2024 | 232.57M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
115.68M
Minimum
Jun 28 2019
498.80M
Maximum
May 03 2021
262.96M
Average
239.16M
Median
Enterprise Value Benchmarks
| Haemonetics Corp | 5.491B |
| Perspective Therapeutics Inc | 817.27M |
| Xtant Medical Holdings Inc | 116.32M |
| Asensus Surgical Inc | 62.82M |
| Catheter Precision Inc | 2.999M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.112M |
| Revenue (Quarterly) | 32.00M |
| Total Expenses (Quarterly) | 32.84M |
| EPS Diluted (Quarterly) | -0.05 |
| Gross Profit Margin (Quarterly) | 51.49% |
| Profit Margin (Quarterly) | -3.48% |
| Earnings Yield | 0.05% |
| Operating Earnings Yield | 2.41% |
| Normalized Earnings Yield | 0.0514 |